NCT03211949 is a NA clinical trial of axillary block in Nerve Block, sponsored by University Hospital, Antwerp.

Who is sponsoring NCT03211949?

NCT03211949 is sponsored by University Hospital, Antwerp.

What drugs are being tested in NCT03211949?

Interventions in NCT03211949: axillary block, Scandicaine.

What condition does NCT03211949 study?

NCT03211949 studies Nerve Block, Surgery, Anesthesia, Brachial Plexus Block.

Is NCT03211949 still recruiting?

NCT03211949 is currently completed. Last updated 4 August 2022.

Last reviewed 2022-08-04 · How we verify

NCT03211949

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topographic Assessment of the Medial Antebrachial Cutaneous Nerve Variations at the Axilla and Above the Cubital Fossa Using Ultrasonography

Completed NA Last updated 4 August 2022

What this trial tests

NA trial testing axillary block in Nerve Block in 150 participants. Completed in 30 January 2020.

Timeline

1 September 2014

Primary endpoint
1 December 2019

30 January 2020

Quick facts

Lead sponsor	University Hospital, Antwerp
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	150
Start date	1 September 2014
Primary completion	1 December 2019
Estimated completion	30 January 2020
Sites	1 location across Belgium

Drugs / interventions tested

axillary block
Scandicaine — full drug profile →

Conditions studied

Nerve Block — all drugs for Nerve Block →
Surgery — all drugs for Surgery →
Anesthesia — all drugs for Anesthesia →
Brachial Plexus Block — all drugs for Brachial Plexus Block →

Sponsor

University Hospital, Antwerp

Who can join

18 and older, any sex, with Nerve Block or Surgery. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

anatomical mapping of the MACN relative to the basilic vein, radial nerve and ulnar nerve
Time frame: up to 30 minutes
an ultrasound image will be stored with the structures marked

Sponsor's own description

Blocking the medial antebrachial cutaneous nerve (MACN) during an axillary block often a subcutaneous wheal of local anesthetics is made what is described as painful. With the improvement of the resolution of the ultrasound machines smaller structures and nerves can be visable. In this study topographic assessment will made of the anatomical variation of the medial antebrachial cutaneous nerve (MACN) by ultrasound in the axilla and 5 cm above the cubital fossa of the arm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of axillary block

Trials testing the same drug.

NCT07209995 — Ultrasound Guided Retroclavicular Infraclavicular Versus Axillary Block as Regional Anesthesia in Obese Patients · NA · enrolling by invitation
NCT05325372 — A Comparative Study Between Infraclavicular and Axillary Blocks for Assessment of Motor Power Using Handgrip Dynamometer · NA · completed

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

NCT07509866 — Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal · NA · recruiting
NCT07346885 — Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery · NA · active not recruiting
NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT07510269 — Investigation of the Effects of Serratus Posterior Superior Intercostal Plane Block and Serratus Anterior Plane Block on · NA · recruiting

Other University Hospital, Antwerp trials

Trials by the same sponsor.

NCT07455422 — A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurr · NA · not yet recruiting
NCT07020715 — A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis · Phase 2 · not yet recruiting
NCT07443761 — Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital. · active not recruiting
NCT06372847 — DISE-HNS Effect Study · NA · recruiting
NCT07189091 — CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03211949 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Antwerp
Last refreshed: 4 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03211949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing